NCCN Guidelines Version 1.2024
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Histologic Transformation (Richter's) and Progression
Chronic Lymphocytic Leukemia-English Version 2023
Chronic Lymphocytic Leukemia-Arabic Version 2021
Continuing Education
Treatment Decisions in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Application of the Latest Data in CLL/SLL: Guidance for Current and Future Treatment Strategies
NCCN Guidelines® Update: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Relapsed/Refractory CLL/SLL: Overcoming Resistance to Covalent BTKi and/or BCL2 Inhibitors
Management of Toxicities of BTK Inhibitors in B-Cell Malignancies
Translations
Chinese Version 3.2023
Portuguese Version 3.2023
Spanish Version 3.2023
Ukrainian Version 3.2023
Adaptations
English (Middle East & North Africa) Version 2.2023
Harmonized
English (Africa) Version 3.2022